PURPOSE: Prostate cancer is a heterogeneous disease with a variable natural history that is not accurately predicted by currently used prognostic tools. EXPERIMENTAL DESIGN: We genotyped 798 prostate cancer cases of Ashkenazi Jewish ancestry treated for localized prostate cancer between June 1988 and December 2007. Blood samples were prospectively collected and de-identified before being genotyped and matched to clinical data. The survival analysis was adjusted for Gleason score and prostate-specific antigen. We investigated associations between 29 single nucleotide polymorphisms (SNP) and biochemical recurrence, castration-resistant metastasis, and prostate cancer-specific survival. Subsequently, we did an independent analysis using a high-resolution panel of 13 SNPs. RESULTS: On univariate analysis, two SNPs were associated (P<0.05) with biochemical recurrence, three SNPs were associated with clinical metastases, and one SNP was associated with prostate cancer-specific mortality. Applying a Bonferroni correction (P<0.0017), one association with biochemical recurrence (P=0.0007) was significant. Three SNPs showed associations on multivariable analysis, although not after correcting for multiple testing. The secondary analysis identified an additional association with prostate cancer-specific mortality in KLK3 (P<0.0005 by both univariate and multivariable analysis). CONCLUSIONS: We identified associations between prostate cancer susceptibility SNPs and clinical end points. The rs61752561 in KLK3 and rs2735839 in the KLK2-KLK3 intergenic region were strongly associated with prostate cancer-specific survival, and rs10486567 in the 7JAZF1 gene were associated with biochemical recurrence. A larger study will be required to independently validate these findings and determine the role of these SNPs in prognostic models. Copyright (c) 2010 AACR.
PURPOSE:Prostate cancer is a heterogeneous disease with a variable natural history that is not accurately predicted by currently used prognostic tools. EXPERIMENTAL DESIGN: We genotyped 798 prostate cancer cases of Ashkenazi Jewish ancestry treated for localized prostate cancer between June 1988 and December 2007. Blood samples were prospectively collected and de-identified before being genotyped and matched to clinical data. The survival analysis was adjusted for Gleason score and prostate-specific antigen. We investigated associations between 29 single nucleotide polymorphisms (SNP) and biochemical recurrence, castration-resistant metastasis, and prostate cancer-specific survival. Subsequently, we did an independent analysis using a high-resolution panel of 13 SNPs. RESULTS: On univariate analysis, two SNPs were associated (P<0.05) with biochemical recurrence, three SNPs were associated with clinical metastases, and one SNP was associated with prostate cancer-specific mortality. Applying a Bonferroni correction (P<0.0017), one association with biochemical recurrence (P=0.0007) was significant. Three SNPs showed associations on multivariable analysis, although not after correcting for multiple testing. The secondary analysis identified an additional association with prostate cancer-specific mortality in KLK3 (P<0.0005 by both univariate and multivariable analysis). CONCLUSIONS: We identified associations between prostate cancer susceptibility SNPs and clinical end points. The rs61752561 in KLK3 and rs2735839 in the KLK2-KLK3 intergenic region were strongly associated with prostate cancer-specific survival, and rs10486567 in the 7JAZF1 gene were associated with biochemical recurrence. A larger study will be required to independently validate these findings and determine the role of these SNPs in prognostic models. Copyright (c) 2010 AACR.
Authors: Nina Mononen; Eija H Seppälä; Priya Duggal; Ville Autio; Tarja Ikonen; Pekka Ellonen; Juha Saharinen; Janna Saarela; Mauno Vihinen; Teuvo L J Tammela; Olli Kallioniemi; Joan E Bailey-Wilson; Johanna Schleutker Journal: Cancer Res Date: 2006-01-15 Impact factor: 12.701
Authors: Christopher A Haiman; Nick Patterson; Matthew L Freedman; Simon R Myers; Malcolm C Pike; Alicja Waliszewska; Julie Neubauer; Arti Tandon; Christine Schirmer; Gavin J McDonald; Steven C Greenway; Daniel O Stram; Loic Le Marchand; Laurence N Kolonel; Melissa Frasco; David Wong; Loreall C Pooler; Kristin Ardlie; Ingrid Oakley-Girvan; Alice S Whittemore; Kathleen A Cooney; Esther M John; Sue A Ingles; David Altshuler; Brian E Henderson; David Reich Journal: Nat Genet Date: 2007-04-01 Impact factor: 38.330
Authors: Thomas Steuber; Andrew J Vickers; Angel M Serio; Ville Vaisanen; Alexander Haese; Kim Pettersson; James A Eastham; Peter T Scardino; Hartwig Huland; Hans Lilja Journal: Clin Chem Date: 2006-12-21 Impact factor: 8.327
Authors: Julius Gudmundsson; Patrick Sulem; Andrei Manolescu; Laufey T Amundadottir; Daniel Gudbjartsson; Agnar Helgason; Thorunn Rafnar; Jon T Bergthorsson; Bjarni A Agnarsson; Adam Baker; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Margret Jakobsdottir; Jianfeng Xu; Thorarinn Blondal; Jelena Kostic; Jielin Sun; Shyamali Ghosh; Simon N Stacey; Magali Mouy; Jona Saemundsdottir; Valgerdur M Backman; Kristleifur Kristjansson; Alejandro Tres; Alan W Partin; Marjo T Albers-Akkers; Javier Godino-Ivan Marcos; Patrick C Walsh; Dorine W Swinkels; Sebastian Navarrete; Sarah D Isaacs; Katja K Aben; Theresa Graif; John Cashy; Manuel Ruiz-Echarri; Kathleen E Wiley; Brian K Suarez; J Alfred Witjes; Mike Frigge; Carole Ober; Eirikur Jonsson; Gudmundur V Einarsson; Jose I Mayordomo; Lambertus A Kiemeney; William B Isaacs; William J Catalona; Rosa B Barkardottir; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson Journal: Nat Genet Date: 2007-04-01 Impact factor: 38.330
Authors: Meredith Yeager; Nick Orr; Richard B Hayes; Kevin B Jacobs; Peter Kraft; Sholom Wacholder; Mark J Minichiello; Paul Fearnhead; Kai Yu; Nilanjan Chatterjee; Zhaoming Wang; Robert Welch; Brian J Staats; Eugenia E Calle; Heather Spencer Feigelson; Michael J Thun; Carmen Rodriguez; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Fredrick R Schumacher; Edward Giovannucci; Walter C Willett; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; Gerald L Andriole; Edward P Gelmann; Margaret Tucker; Daniela S Gerhard; Joseph F Fraumeni; Robert Hoover; David J Hunter; Stephen J Chanock; Gilles Thomas Journal: Nat Genet Date: 2007-04-01 Impact factor: 38.330
Authors: Andrew J Stephenson; Michael W Kattan; James A Eastham; Zohar A Dotan; Fernando J Bianco; Hans Lilja; Peter T Scardino Journal: J Clin Oncol Date: 2006-08-20 Impact factor: 44.544
Authors: Hans Lilja; David Ulmert; Thomas Björk; Charlotte Becker; Angel M Serio; Jan-Ake Nilsson; Per-Anders Abrahamsson; Andrew J Vickers; Göran Berglund Journal: J Clin Oncol Date: 2007-02-01 Impact factor: 44.544
Authors: John Lai; Mary-Anne Kedda; Kimberly Hinze; Robert L G Smith; John Yaxley; Amanda B Spurdle; C Phillip Morris; Jonathan Harris; Judith A Clements Journal: Carcinogenesis Date: 2006-12-06 Impact factor: 4.944
Authors: S Lilly Zheng; Jielin Sun; Yu Cheng; Ge Li; Fang-Chi Hsu; Yi Zhu; Bao-Li Chang; Wennuan Liu; Jin Woo Kim; Aubrey R Turner; Marta Gielzak; Guifang Yan; Sarah D Isaacs; Kathleen E Wiley; Jurga Sauvageot; Huann-Sheng Chen; Robin Gurganus; Leslie A Mangold; Bruce J Trock; Henrik Gronberg; David Duggan; John D Carpten; Alan W Partin; Patrick C Walsh; Jianfeng Xu; William B Isaacs Journal: J Natl Cancer Inst Date: 2007-10-09 Impact factor: 13.506
Authors: C Gu; Q Li; Y Zhu; Y Qu; G Zhang; M Wang; Y Yang; J Wang; L Jin; Q Wei; D Ye Journal: Prostate Cancer Prostatic Dis Date: 2015-08-04 Impact factor: 5.554
Authors: Brian T Helfand; Kimberly A Roehl; Phillip R Cooper; Barry B McGuire; Liesel M Fitzgerald; Geraldine Cancel-Tassin; Jean-Nicolas Cornu; Scott Bauer; Erin L Van Blarigan; Xin Chen; David Duggan; Elaine A Ostrander; Mary Gwo-Shu; Zuo-Feng Zhang; Shen-Chih Chang; Somee Jeong; Elizabeth T H Fontham; Gary Smith; James L Mohler; Sonja I Berndt; Shannon K McDonnell; Rick Kittles; Benjamin A Rybicki; Matthew Freedman; Philip W Kantoff; Mark Pomerantz; Joan P Breyer; Jeffrey R Smith; Timothy R Rebbeck; Dan Mercola; William B Isaacs; Fredrick Wiklund; Olivier Cussenot; Stephen N Thibodeau; Daniel J Schaid; Lisa Cannon-Albright; Kathleen A Cooney; Stephen J Chanock; Janet L Stanford; June M Chan; John Witte; Jianfeng Xu; Jeannette T Bensen; Jack A Taylor; William J Catalona Journal: Hum Genet Date: 2015-02-26 Impact factor: 4.132
Authors: Zorana Z Nikolić; Goran N Brajušković; Dušanka Lj Savić Pavićević; Aleksandar S Kojić; Vinka D Vukotić; Saša M Tomović; Snežana J Cerović; Vladimir Filipović; Duro Mišljenović; Stanka P Romac Journal: Int J Clin Exp Med Date: 2012-11-18
Authors: Zorana Z Nikolić; Ana S Branković; Dušanka L J Savić-Pavićević; Stefan M Preković; Vinka D Vukotić; Snežana J Cerović; Nataša N Filipović; Saša M Tomović; Stanka P Romac; Goran N Brajušković Journal: Clin Transl Sci Date: 2014-01-14 Impact factor: 4.689
Authors: Irene M Shui; Sara Lindström; Adam S Kibel; Sonja I Berndt; Daniele Campa; Travis Gerke; Kathryn L Penney; Demetrius Albanes; Christine Berg; H Bas Bueno-de-Mesquita; Stephen Chanock; E David Crawford; W Ryan Diver; Susan M Gapstur; J Michael Gaziano; Graham G Giles; Brian Henderson; Robert Hoover; Mattias Johansson; Loic Le Marchand; Jing Ma; Carmen Navarro; Kim Overvad; Fredrick R Schumacher; Gianluca Severi; Afshan Siddiq; Meir Stampfer; Victoria L Stevens; Ruth C Travis; Dimitrios Trichopoulos; Paolo Vineis; Lorelei A Mucci; Meredith Yeager; Edward Giovannucci; Peter Kraft Journal: Eur Urol Date: 2014-01-04 Impact factor: 20.096
Authors: Mark M Pomerantz; Lillian Werner; Wanling Xie; Meredith M Regan; Gwo-Shu Mary Lee; Tong Sun; Carolyn Evan; Gillian Petrozziello; Mari Nakabayashi; William K Oh; Philip W Kantoff; Matthew L Freedman Journal: Cancer Prev Res (Phila) Date: 2011-03-02